Orange Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Orange
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Orange News
Amazon, Google named by EU among 'critical' tech providers for finance industry
EU regulators on Tuesday designated 19 technology companies, including Amazon Web Services, Google Cloud and Microsoft, as critical third-party computing providers ...
New immersive Shroud of Turin museum opens in Southern California
A new million, 10,000-square-foot Shroud of Turin museum on the chancery campus of the Diocese of Orange in Southern California opened to visitors Wednesday.
'Stranger Things' begins its final season: 10 reasons why the Netflix show mattered
"Stranger Things" captivated audiences worldwide, becoming a cultural icon and influencing television, fashion and nostalgia-driven trends.
RNA therapy silences KRAS gene and boosts immune attack on cancer cells
Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that ...